Breakpoint Therapeutics

Description: Breakpoint Therapeutics develops first-in-class anti-cancer drugs targeting DNA damage response to treat therapy-resistant cancers.

Country: Germany

Based in: Hamburg

Founded: 2019

Funding Stage: Seed

Tags: ['Biotechnology', 'Health Care', 'Therapeutics']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.